News

Charnwood Molecular collaboration with Forendo Pharma provides Development candidates

A two-year-long discovery chemistry collaboration between Charnwood Molecular and Forendo Pharma has seen compounds move from discovery to pre-clinical development. Charnwood Molecular and Forendo Pharma have been collaborating since September 2015, with Charnwood Molecular synthesising challenging steroidal analogues of a hit compound initially identified at Forendo Pharma. Multi-centred lead optimisation …

Read More »

Launch of new collaboration to tackle lung disease

Leicester and Nottingham universities have announced a new strategic research collaboration with GSK, using genetics to aid the development of new medicines for Chronic Obstructive Pulmonary Disease (COPD) and related airway disorders. The £1.24m investment over three years provides an East Midlands-focused boost to the Life Sciences Sector Deal of …

Read More »

Local deaf charity’s marathon staff challenge

One of The Ear Foundation’s own team has decided to take on the mammoth challenge of running The London Marathon in support of the charity she works for. Sarah Hoyle has bravely decided to take up the challenge and will be running the world renowned marathon in the capital on …

Read More »

Locate Therapeutics Successfully Achieves ISO 13845 Certification for Design, Development and Control of Manufacture for Resorbable Biomaterials

Locate Therapeutics, a leading UK regenerative medicine company has announced that it has successfully achieved EN ISO 13845:2016 certification for the design control and control of manufacturing of resorbable injectable tissue scaffolds for use in bone repair and regeneration. Currently Locate is developing a pipeline of combination therapies using its patented TAOS®* polymer-based matrix as a …

Read More »

XenoGesis moves into BioHub as expansion plans continue

Leading UK-based DMPK provider has taken tenancy at BioHub, Alderley Park, increasing its foothold in the UK. XenoGesis which was founded in 2011 by Dr Richard Weaver, has seen continued growth at its headquarters at BioCity Nottingham. Now employing 25 members of staff, the business has steadily grown into larger …

Read More »

£500k Funding Boost for Regenerative Medicine Firm

A regenerative medicine company which has developed a therapy that can help prevent sight loss has completed a £500,000 funding round backed by Mercia Fund Managers, angel investors and the University of Nottingham. The investment will allow Nottingham-based NuVision Biotherapies to further develop its product range, add to its management …

Read More »

AdamsonJones move to larger offices to accommodate Leicester growth

AdamsonJones firm of patent and trade mark attorneys, has relocated to larger business premises less than a year from opening its latest office in Leicester. The intellectual property specialists, who have office space in Nottingham, Leicester and London, are already seeing impressive growth following the company’s decision to open an office …

Read More »

Olberon appoint Affiliate Partner for MEA Region

Olberon Ltd, a medical device innovation company based in Nottingham, has recently appointed TB Medex SAS as their Affiliate Partner MEA. This is the first appointment as part of Olberon’s ambitious global growth programme, for its unique portfolio of products which includes the Otorhinoscope and the Vacuderm. CEO, Dr Arash …

Read More »

Susan Hallam awarded MBE in Queen’s New Years Honours

Susan Hallam, Director of Hallam Internet Ltd, was made an MBE in the 2018 Queen’s New Years honours. This appointment is in recognition of Susan’s contributions to entrepreneurship and innovation, and her lifetime work in digital marketing. The awarding of an MBE recognises Susan’s national and international reputation for digital …

Read More »

XenoGesis ramps up growth plans with appointment of new global head of business development

XenoGesis has appointed Dr Rachel Hemsley as global head of business development in a drive to support its ambitious growth plans. The Nottingham-based biotechnology company is the UK’s largest independent laboratory-based contract research organisation (CRO) specialising in preclinical drug metabolism and pharmacokinetics (DMPK) – enabling it to provide expert interpretation …

Read More »

Two Accelerator Alumni

Two years apart  The unique tools of the BioCity business accelerator support innovation, growth and success across all industry sectors and accelerating businesses, regardless of company age, experience or time commitments. To date, Biocity accelerator alumni range from technology inventors, industrial scientists and students with just the spark of an …

Read More »